Novartis Services, Inc.
Registered Principal Details
Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Vas Narasimhan
US Country Head of Government Affairs
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Vas Narasimhan
US Country Head of Government Affairs
Contact
DC
Daniel Casserly
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(202) 662-4361
(202) 628-4764
dan.casserly@novartis.com
http://www.novartis.com
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(202) 662-4361
(202) 628-4764
dan.casserly@novartis.com
http://www.novartis.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 679
Toggle details
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
For
Notification Date12/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Toggle details
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
For
Notification Date11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Biosimilars
Biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
8/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
8/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $7,000.00 |
2017 July - December $15,800.82 |
2018 January - June $11,263.22 |
2018 July - December $7,500.00 |
Total $41,564.05 |
| Total Hours Communicating | 2017 January - June 0.50 |
2017 July - December 16.00 |
2018 January - June 8.25 |
2018 July - December 2.00 |
Total 26.75 |
| Total Hours Other | 2017 January - June 4.50 |
2017 July - December 28.50 |
2018 January - June 28.00 |
2018 July - December 9.00 |
Total 70.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 22% |
2018 January - June 10% |
2018 July - December |
Total 14% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 38% |
2018 January - June 75% |
2018 July - December |
Total 45% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 20% |
2018 January - June |
2018 July - December |
Total 9% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication